Shockwave Medical Inc., a unit of Johnson & Johnson Medtech, reported positive 30-day results from the EMPOWER CAD trial, which used its intravascular lithotripsy system in women with complex, calcified coronary artery disease. The results from the first prospective, real-world percutaneous coronary intervention study in female patients confirmed the benefit of coronary patients as seen in other retrospective analyses. Read More
Galvanize Therapeutics Inc.’s Aliya pulsed electrical field system could enable surgeons to perform a biopsy and ablate lung tumors at the same time, a study in the Journal of Surgical Oncology indicates. Read More
Phase Scientific International Ltd. raised $34 million in a series A round to accelerate research and development of its early disease detection technology for multiple cancers, women's health issues, and infectious diseases. Read More
Innovative Health LLC, of Scottsdale, Ariz., obtained a jury verdict of $147 million against Johnson & Johnson’s Biosense Webster unit for practices that thwarted the use of less costly reprocessed medical devices. Read More
The U.S. Department of Justice said the CEO of Spinefrontier Inc., Kingsley Chin, entered a guilty plea in connection with allegations that he made false statements about payments made to surgeons for consulting work the physicians did not perform. Read More
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Bridgebio, Galvanize, Shockwave, SIME Diagnostics. Read More
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Ambiq, Atia Vision, Betaliq, Biolife Delaware, Cardiomedive, Eyenovia, Eurobio, Frame, Illumina, Labcorp, Merit Medical, Reframe, Signios Biosciences, Tempus AI, Verastem Oncology. Read More
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Hyalex Orthopaedics, Inmode, Neuraxis, Stryker. Read More
